These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2597825)

  • 1. Safer contrast agents?
    Dawson P; Allison DJ
    Br J Hosp Med; 1989 Nov; 42(5):406-7. PubMed ID: 2597825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iodinated radiographic contrast media: comparison of low-osmolar with conventional ionic agents [corrected].
    Rubin JD; Cohan RH
    Curr Opin Radiol; 1991 Oct; 3(5):637-45. PubMed ID: 1931499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Iodinated contrast media and nephropathy--new recommendations. Estimated creatine clearance for better assessment of renal function and dosage].
    Nyman U; Hietala SO; Hellström M; Aspelin P; Björkdahl P; Albrechtsson U; Magnusson A; Måre K; Törnquist C; Ringertz H; Sterner G; Westberg G; Berne C
    Lakartidningen; 2003 Mar; 100(10):840-3, 846-8. PubMed ID: 12680021
    [No Abstract]   [Full Text] [Related]  

  • 4. [Must patients fast before a radiologic examination with injection of an iodinated contrast media?].
    Roy C; Marcus C; Menanteau B; Blum A; Issenuth J; Raffaelli C; Chanalet S; Padovani B
    J Radiol; 1998 Sep; 79(9):892-6. PubMed ID: 9791773
    [No Abstract]   [Full Text] [Related]  

  • 5. [Iodinated contrast media and nephropathy. Estimated creatinine clearance for better assessment of renal function and dosage].
    Nyman U; Hietala SO; Hellström M; Aspelin P; Björkdahl P; Albrechtsson U; Magnusson A; Måre K; Törnquist C; Ringertz H; Sterner G; Westberg G; Berne C
    Ugeskr Laeger; 2004 Jun; 166(26-31):2566-72. PubMed ID: 15285166
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyperthyroidism after iodinated contrast medium.
    Blum M; Weinberg U; Shenkman L; Hollander CS
    N Engl J Med; 1974 Jul; 291(1):24-5. PubMed ID: 4832400
    [No Abstract]   [Full Text] [Related]  

  • 7. [Selection of contrast media: current status of understanding].
    Briguori C
    G Ital Cardiol (Rome); 2009 Feb; 10(2):79-87. PubMed ID: 19348144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of intravascular low-osmolality contrast agents.
    Swanson DP; Thrall JH; Shetty PC
    Clin Pharm; 1986 Nov; 5(11):877-91. PubMed ID: 3780159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adverse reactions to parenterally administered iodinated contrast media].
    Cuñat A; Zaragozà E; Diago T; Chuliá R
    Med Clin (Barc); 1992 Apr; 98(15):597. PubMed ID: 1602876
    [No Abstract]   [Full Text] [Related]  

  • 10. Iodinated contrast agents in neuroradiology.
    Zagoria RJ
    Neuroimaging Clin N Am; 1994 Feb; 4(1):1-8. PubMed ID: 8130943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iodinated contrast media: new versus old.
    Johnson LA; Katzberg RW
    Contemp Urol; 1991 Jun; 3(6):27-8; 33-9. PubMed ID: 10148061
    [No Abstract]   [Full Text] [Related]  

  • 12. [Renal tolerance of iodinated low osmolality contrast agents. Clinical and experimental aspects].
    Deray G; Dubois M; Bellin MF; Grellet J; Jacobs C
    J Radiol; 1990; 71(6-7):439-44. PubMed ID: 2254874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-osmolality versus high-osmolality contrast material.
    Korn WT; Bettmann MA
    Curr Opin Radiol; 1992 Apr; 4(2):9-15. PubMed ID: 1554592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immediate reactions following iodinated contrast media injection: a study of 38 cases.
    Dewachter P; Laroche D; Mouton-Faivre C; Bloch-Morot E; Cercueil JP; Metge L; Carette MF; Vergnaud MC; Clément O
    Eur J Radiol; 2011 Mar; 77(3):495-501. PubMed ID: 19833466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties and pharmacology of intravascular radiocontrast media.
    Morris TW
    Can J Cardiol; 1987 Nov; 3 Suppl A():6A-10A. PubMed ID: 3435852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iodinated contrast media and the kidney.
    Weisbord SD
    Rev Cardiovasc Med; 2008; 9 Suppl 1():S14-23. PubMed ID: 18418313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Betamethasone in the prevention of allergic complications caused by intravenous iodine contrast media].
    Chevrot A; Chevrot L; Sarrat P; Wallays C
    Ann Radiol (Paris); 1988; 31(3):193-6. PubMed ID: 3218843
    [No Abstract]   [Full Text] [Related]  

  • 18. [Problems and risks in the intravenous administration of iodinated contrast media].
    Sehr A; Strejcek J
    Cesk Radiol; 1987 Dec; 41(6):354-61. PubMed ID: 3442865
    [No Abstract]   [Full Text] [Related]  

  • 19. [Guideline 'Precautionary measures for contrast media containing iodine'].
    van Dijk Azn R; Wetzels JF; ten Dam MA; Aarts NJ; Schimmelpenninck-Scheiffers ML; Freericks MP; Said SA; Geenen RW; Stuurman A; van Everdingen JJ
    Ned Tijdschr Geneeskd; 2008 Mar; 152(13):742-6. PubMed ID: 18461890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preston M. Hickey memorial lecture. Ionic and nonionic iodinated contrast media: evolution and strategies for use.
    McClennan BL
    AJR Am J Roentgenol; 1990 Aug; 155(2):225-33. PubMed ID: 2115244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.